Latest Breaking News On - Monsoon communications - Page 1 : comparemela.com

Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor

Global retina expert joins to support sozinibercept development and launch preparationMELBOURNE, Australia, Feb. 19, 2024 (GLOBE NEWSWIRE) Opthea Limited (ASX:OPT; NASDAQ:OPT, “Opthea”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, today announced the appointment of Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor. An internationally recognized retina specialist and clinical scientist, Dr. Khanani i

Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor - Opthea (NASDAQ:OPT)

MELBOURNE, Australia, Feb. 19, 2024 (GLOBE NEWSWIRE) Opthea Limited ((ASX:OPT, NASDAQ:OPT, "Opthea")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive

Opthea Strengthens Team with Key Clinical and Regulatory Hires

Opthea to Receive US$35M Commitment and Additional US$50M Funding

Opthea Receives A$8.8 million R&D Tax Incentive

MELBOURNE, Australia, Dec. 19, 2023 Opthea Limited , a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced.